Table of Contents PART 01: Executive summary PART 02: Scope of  the report Market overview Vendor analysis Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation  by underlying cause PART 07: Market segmentation by services Market overview ART services market in US Infertility drugs services market in US PART 08: Market drivers PART 09: Impact of drivers PART 10: Market challenges PART 11: Impact of drivers and challenges PART 12: Market trends PART 13: Vendor landscape Competitive scenario Other prominent vendors PART 14: Key Vendor Analysis CARE Fertility CooperSurgical Ferring Pharmaceuticals Monash IVF Merck Vitrolife PART 15: Appendix List of abbreviations PART 16: Explore Technavio List of Exhibits Exhibit 01: US infertility services market segmentation: Overview Exhibit 02: Product offerings Exhibit 03: Assessment of regulatory bodies Exhibit 04: Snapshot: Infertility services market in US Exhibit 05: US fertility chart 2015 Exhibit 06: Stages of infertility treatment Exhibit 07: Infertility services market in the US 2016-2021 ($ billions) Exhibit 08: Side effects and success rates of infertility services in US Exhibit 09: Impact of various factors on infertility services in US Exhibit 10: Recommendations to vendors Exhibit 11: Five forces analysis Exhibit 12: Infertility services market in US by underlying cause Exhibit 13: Diagnosis of infertility Exhibit 14: Market segmentation by services 2016-2021(in %) Exhibit 15: Snapshot: US fertility services market by product Exhibit 16: Categories of ART services 2016 Exhibit 17: IVF overview Exhibit 18: ART services market in US 2016-2021 ($ billions) Exhibit 19: Comparison of fresh and frozen ART cycle Exhibit 20: Infertility drugs services market in US 2016-2021($ billions) Exhibit 21: Success rate of IVF procedures Exhibit 22: ART procedures in US (in thousands) Exhibit 23: Obesity prevalence in the US (2015) Exhibit 24: Infertility rates by age Exhibit 25: US birth rates by women Exhibit 26: Impact of drivers Exhibit 27: Cost breakdown of IVF by various stages in US Exhibit 28: Impact of drivers and challenges Exhibit 29: Notable M&A activity Exhibit 30: Same sex married couples in US Exhibit 31: CARE Fertility: Profile Exhibit 32: CARE Fertility: Strength analysis Exhibit 33: CARE Fertility: Strategy assessment Exhibit 34: CARE Fertility: Opportunity assessment Exhibit 35: CooperSurgical: Profile Exhibit 36: CooperSurgical: Strength analysis Exhibit 37: CooperSurgical: Growth strategy assessment Exhibit 38: CooperSurgical: Opportunity assessment Exhibit 39: Ferring Pharmaceuticals: Profile Exhibit 40: Ferring Pharmaceuticals: Strength analysis Exhibit 41: Ferring Pharmaceuticals: Strategy assessment Exhibit 42: Ferring Pharmaceuticals: Opportunity assessment Exhibit 43: Monash IVF: Profile Exhibit 44: Monash IVF: Strength analysis Exhibit 45: Monash IVF: Strategy assessment Exhibit 46: Monash IVF: Opportunity assessment Exhibit 47: Merck: Profile Exhibit 48: Merck: Strength analysis Exhibit 49: Merck: Strategy assessment Exhibit 50: Merck: Opportunity assessment Exhibit 51: Vitrolife: Profile Exhibit 52: Vitrolife: Strength analysis Exhibit 53: Vitrolife: Strategy assessment Exhibit 54: Vitrolife: Opportunity assessment

CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, Xytex Cryo International.